Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS.
about
Rationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach UsVisfatin levels in patients with severe pneumoniaLife stress and diminished expression of genes encoding glucocorticoid receptor and beta2-adrenergic receptor in children with asthmaEffect of chlorogenic acid (5-Caffeoylquinic Acid) isolated from Baccharis oxyodonta on the structure and pharmacological activities of secretory phospholipase A2 from Crotalus durissus terrificus.Distinct proteasome subpopulations in the alveolar space of patients with the acute respiratory distress syndromePeripheral and central effects of repeated social defeat stress: monocyte trafficking, microglial activation, and anxiety.The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis.Glucocorticosteroid in treatment of severe pneumonia.The effect of etomidate on adrenal function in critical illness: a systematic review.Stress-Induced Microglia Activation and Monocyte Trafficking to the Brain Underlie the Development of Anxiety and Depression.[Addison's disease].Social disruption induces lung inflammation.An evaluation of 3-rhamnosylquercetin, a glycosylated form of quercetin, against the myotoxic and edematogenic effects of sPLA 2 from Crotalus durissus terrificus.Is prolonged low-dose glucocorticoid treatment beneficial in community-acquired pneumonia?Genetics of postoperative complications following thoracic surgery.Critical Illness-Related Corticosteroid Insufficiency in Patients with Low Cardiac Output Syndrome after Cardiac Surgery.Saquinavir plus methylprednisolone ameliorates experimental acute lung injury
P2860
Q26744478-2C3F341B-0798-4DA7-A100-B1EFE5884AA3Q34031821-C3164D32-3A79-48E9-939F-7AAA2C1DCB17Q34481730-79097729-E00F-4BCD-88C1-541732EAC250Q35279279-5111496F-722B-4596-83D9-DB3D54D80B16Q35738931-9D2D6AF3-86F7-4162-8692-920F3F68EE41Q35954533-A05F4BF0-2EFF-4C2A-A964-874A12C13375Q36132386-397DCFB9-6799-40D9-8612-7BE8D6D4F089Q37398445-8FAF9E5E-7556-4E68-8C65-8354AB608DF6Q37849626-EA95C806-A39D-4753-82A0-BBF697EE6249Q38879652-4CF66DE1-5521-479A-906E-ADFF0B7277A1Q40277028-969BF048-730F-4BE8-A869-A9338A675838Q41807544-1A078105-3649-48B9-BFB4-F84097E90DE0Q42181534-07109C68-D3B4-47B3-B5AD-D96F615F85C4Q44127294-322F27E3-CE10-4E8A-AD85-CD773752AE7BQ48632226-27B691DF-4733-4680-BBA7-8793F261FA36Q54234550-E8166F3B-F73E-42D5-87E4-7A6F1B66D841Q58799169-7C67D86F-FF87-4FB0-A5C7-16FBE75BB4B4
P2860
Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS.
@ast
Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS.
@en
type
label
Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS.
@ast
Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS.
@en
prefLabel
Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS.
@ast
Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS.
@en
P2860
P356
P1476
Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS.
@en
P2093
Charles R Yates
G Umberto Meduri
P2860
P356
10.1196/ANNALS.1321.004
P407
P577
2004-06-01T00:00:00Z